GBIP in Switzerland: Antimicrobial resistance

Explore global opportunities in the life sciences sector

Innovate UK is inviting innovative UK businesses with expertise in antimicrobial resistance (AMR) to apply for its Global Business Innovation Programme (GBIP) in Switzerland.

Why Switzerland?

The Swiss methodology to tackle AMR is a One Health approach which highlights a deep understanding of, and commitment to the problems of AMR. The Swiss life sciences industry, particularly in the Basel region, is a world leader and the driving force of the Swiss economy, housing some 800 life sciences companies, including headquarters of Roche, Novartis and Sandoz.

Focus areas

This GBIP is for One Health AMR and is particularly relevant for businesses with a focus on diagnostics, antimicrobials, preventatives, stewardship and phage therapy at the core of their value proposition.

Benefits of applying

By participating in the GBIP, you'll get the chance to:

• attend preparatory workshops in the UK
• join a 5-day market visit in Switzerland
• participate in a follow-up workshop to exploit opportunities
• receive ongoing support from an Innovate UK Innovation and Growth Specialist

As part of the market visit, you'll also get to:

• explore opportunities and find innovation partners for AMR collaboration in Switzerland
• visit major tech clusters to gain a better understanding of the challenges and opportunities in Switzerland
• meet key AMR players at the 9th AMR Conference in Basel
• improve your company value proposition to international partners

If your business wants to expand globally and form new collaborations, don't miss the chance to apply. Join the applicant briefing on 9 October 2024 for more details.

Find out more and apply to this AMR GBIP in Switzerland.

For additional advice, local businesses can email Alayne Kinver, Innovate UK Business Growth Project Manager in Northern Ireland: Alayne.Kinver@innovateukedge.ukri.org.

First published 6 September 2024